Literature DB >> 15336555

Pancreatic tumor cells influence the composition of the extracellular matrix.

Jörg Köninger1, Thomas Giese, Fabio F di Mola, Moritz N Wente, Irene Esposito, Max G Bachem, Nathalia A Giese, Markus W Büchler, Helmut Friess.   

Abstract

The malignant behavior of cancers depends on the microenvironmental context. We investigated compositional alterations of the extracellular matrix (ECM) in pancreatic cancer, with special emphasis on the proteoglycans decorin, lumican, and versican. Compared with normal controls (n=18), marked overexpression of these proteoglycans was observed in pancreatic cancer tissues (n=30) by quantitative RT-PCR (p<0.0001). Immunohistochemistry revealed abundance of proteoglycans in the ECM of pancreatic cancer specimens, whereas tumor cells themselves were devoid of either decorin, lumican or versican. RT-PCR confirmed pancreatic stellate cells (PSCs) as the major source of these proteins. Interestingly, TGFbeta1 and conditioned medium derived from pancreatic cancer cell lines synergistically suppressed the expression of known anti-tumor factors decorin and lumican, but stimulated the expression of pro-metastatic factor versican in cultured PSCs. These findings indicate that malignant cells can actively influence the composition of the ECM through TGFbeta1 and other soluble factors, altering their microenvironment in a tumor-favorable way.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15336555     DOI: 10.1016/j.bbrc.2004.08.008

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  24 in total

1.  Pancreatic stellate cells: new kids become mature.

Authors:  M Pinzani
Journal:  Gut       Date:  2006-01       Impact factor: 23.059

Review 2.  The pancreatic stellate cell: a star on the rise in pancreatic diseases.

Authors:  M Bishr Omary; Aurelia Lugea; Anson W Lowe; Stephen J Pandol
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

3.  Identification of RAB2A and PRDX1 as the potential biomarkers for oral squamous cell carcinoma using mass spectrometry-based comparative proteomic approach.

Authors:  Kaushik Kumar Dey; Ipsita Pal; Rashmi Bharti; Goutam Dey; B N Prashanth Kumar; Shashi Rajput; Aditya Parekh; Sheetal Parida; Priyanka Halder; Indranil Kulavi; Mahitosh Mandal
Journal:  Tumour Biol       Date:  2015-07-11

Review 4.  Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatment.

Authors:  Xuqi Li; Qingyong Ma; Qinhong Xu; Wanxing Duan; Jianjun Lei; Erxi Wu
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 5.  Therapeutic potential of perineural invasion, hypoxia and desmoplasia in pancreatic cancer.

Authors:  Han Liu; Qingyong Ma; Qinhong Xu; Jianjun Lei; Xuqi Li; Zheng Wang; Erxi Wu
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 6.  Stromal reengineering to treat pancreas cancer.

Authors:  Ingunn M Stromnes; Kathleen E DelGiorno; Philip D Greenberg; Sunil R Hingorani
Journal:  Carcinogenesis       Date:  2014-06-07       Impact factor: 4.944

Review 7.  Antithetic roles of proteoglycans in cancer.

Authors:  Elena Garusi; Silvia Rossi; Roberto Perris
Journal:  Cell Mol Life Sci       Date:  2011-10-02       Impact factor: 9.261

8.  Biglycan expression and clinical outcome in patients with pancreatic adenocarcinoma.

Authors:  Giuseppe Aprile; Claudio Avellini; Michele Reni; Micol Mazzer; Luisa Foltran; Diego Rossi; Stefano Cereda; Emiliana Iaiza; Gianpiero Fasola; Andrea Piga
Journal:  Tumour Biol       Date:  2012-09-25

9.  Transforming Growth Factor-β Limits Secretion of Lumican by Activated Stellate Cells within Primary Pancreatic Adenocarcinoma Tumors.

Authors:  Ya'an Kang; David Roife; Yeonju Lee; Hailong Lv; Rei Suzuki; Jianhua Ling; Mayrim V Rios Perez; Xinqun Li; BingBing Dai; Michael Pratt; Mark J Truty; Deyali Chatterjee; Huamin Wang; Ryan M Thomas; Yu Wang; Eugene J Koay; Paul J Chiao; Matthew H Katz; Jason B Fleming
Journal:  Clin Cancer Res       Date:  2016-04-28       Impact factor: 12.531

Review 10.  Desmoplasia of pancreatic ductal adenocarcinoma.

Authors:  Stephen Pandol; Mouad Edderkaoui; Ilya Gukovsky; Aurelia Lugea; Anna Gukovskaya
Journal:  Clin Gastroenterol Hepatol       Date:  2009-11       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.